Topics

LeMaitre Vascular Inc LMAT Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125

16:16 EDT 11 Oct 2019 | BioPortfolio Reports

LeMaitre Vascular Inc LMAT Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.


The profile contains critical company information including:


Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Highlights


LeMaitre Vascular Inc LeMaitre Vascular provides medical devices and services for the treatment of peripheral vascular diseases. The company develops, manufactures, and markets disposable and implantable devices that vascular surgeons use in arteries and veins outside the heart in open vascular surgeries and minimally invasive procedures. Its product portfolio includes angioscopes, balloon catheters, carotid shunts, radiopaque tapes, powered phlebectomy devices, valvulotomes, remote endarterectomy devices, vascular grafts, patches and closure systems. It also offers human tissue cryopreservation services. LeMaitre Vascular sells its products through direct sales force and subsidiaries in North America, Europe, AsiaPacific , and through distributors in other geographies. LeMaitre Vascular is headquartered in Burlington, Massachusetts, the US.


LeMaitre Vascular Inc Key Recent Developments


May 01,2019: LeMaitre Vascular announces Q1 2019 financial results

Feb 19,2019: LeMaitre Vascular announces Q4 2018 financial results

Oct 04,2018: LeMaitre Vascular Announces Preliminary Q3 2018 Results

Apr 25,2018: LeMaitre Q1 2018 Sales $26.0mm +8%, EPS $0.19 +17%

Feb 21,2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017


Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.


Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.


Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.


Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.


Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Note: Some sections may be missing if data is unavailable for the company

Original Article: LeMaitre Vascular Inc LMAT Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125

NEXT ARTICLE

More From BioPortfolio on "LeMaitre Vascular Inc LMAT Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125"

Quick Search

Relevant Topics

Vascular
Vascular relates to blood vessels (Oxford Medical Dictionary) and can be used to describe the supply of blood, a disease affecting the blood vessels or molecules associated with these structures. For example, <!--LGfEGNT2Lhm-->atherosclerosis ...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...